The multispecific organic anion transporter family: properties and pharmacological significance

被引:80
作者
Miyazaki, H
Sekine, T
Endou, H
机构
[1] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto 8608556, Japan
[3] Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan
基金
日本学术振兴会;
关键词
D O I
10.1016/j.tips.2004.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Physiological and pharmacological studies indicate that the renal and hepatic organic anion transport systems are responsible for the elimination of numerous compounds, such as drugs, environmental substances and metabolites of both endogenous and exogenous origins. Recently, the molecular identity of the organic anion transport system, the OAT family, was revealed. To date, six OAT members have been identified and shown to have important roles not only in detoxification in the kidneys, liver and brain, but also in the reabsorption of essential compounds such as urate. The OAT family members are closely associated with the pharmacokinetics, drug-drug interactions and toxicity of anionic substances such as nephrotoxic drugs and uremic toxins. The molecular characterization of the OAT family encoded by SLC22A will be discussed.
引用
收藏
页码:654 / 662
页数:9
相关论文
共 84 条
[1]   Structure and mechanism of the lactose permease of Escherichia coli [J].
Abramson, J ;
Smirnova, I ;
Kasho, V ;
Verner, G ;
Kaback, HR ;
Iwata, S .
SCIENCE, 2003, 301 (5633) :610-615
[2]  
ANZAI N, IN PRESS J BIOL CHEM
[3]   Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene [J].
Bahn, A ;
Prawitt, D ;
Buttler, D ;
Reid, G ;
Enklaar, T ;
Wolff, NA ;
Ebbinghaus, C ;
Hillemann, A ;
Schulten, HJ ;
Gunawan, B ;
Füzesi, L ;
Zabel, B ;
Burckhardt, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :623-630
[4]   Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1) [J].
Bahn, A ;
Knabe, M ;
Hagos, Y ;
Rödiger, M ;
Godehardt, S ;
Graber-Neufeld, DS ;
Evans, KK ;
Burckhardt, G ;
Wright, SH .
MOLECULAR PHARMACOLOGY, 2002, 62 (05) :1128-1136
[5]   Expression studies and functional characterization of renal human organic anion transporter 1 isoforms [J].
Bahn, A ;
Ebbinghaus, C ;
Ebbinghaus, D ;
Ponimaskin, EG ;
Füzesi, L ;
Burckhardt, G ;
Hagos, Y .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (04) :424-430
[6]   Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux [J].
Bakhiya, N ;
Bahn, A ;
Burckhardt, G ;
Wolff, NA .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2003, 13 (05) :249-256
[7]   A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse [J].
Brady, KP ;
Dushkin, H ;
Förnzler, D ;
Koike, T ;
Magner, F ;
Her, H ;
Gullans, S ;
Segre, GV ;
Green, RM ;
Beier, DR .
GENOMICS, 1999, 56 (03) :254-261
[8]   Gender-specific and developmental influences on the expression of rat organic anion transporters [J].
Buist, SCN ;
Cherrington, NJ ;
Choudhuri, S ;
Hartley, DP ;
Klaassen, CD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :145-151
[9]   Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta [J].
Cha, SH ;
Sekine, T ;
Kusuhara, H ;
Yu, E ;
Kim, JY ;
Kim, DK ;
Sugiyama, Y ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :4507-4512
[10]   Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286